ro 43-5054 has been researched along with lamifiban in 3 studies
Studies (ro 43-5054) | Trials (ro 43-5054) | Recent Studies (post-2010) (ro 43-5054) | Studies (lamifiban) | Trials (lamifiban) | Recent Studies (post-2010) (lamifiban) |
---|---|---|---|---|---|
9 | 0 | 0 | 84 | 12 | 2 |
Protein | Taxonomy | ro 43-5054 (IC50) | lamifiban (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.0157 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.0157 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alig, L; Edenhofer, A; Hadváry, P; Hürzeler, M; Knopp, D; Müller, M; Steiner, B; Trzeciak, A; Weller, T | 1 |
Fitzgerald, DJ; Murphy, NP; Pratico, D | 1 |
Carroll, RC; Liu, F; Morris, SA; Wang, XF | 1 |
3 other study(ies) available for ro 43-5054 and lamifiban
Article | Year |
---|---|
Low molecular weight, non-peptide fibrinogen receptor antagonists.
Topics: Amino Acid Sequence; Animals; Dogs; Fibrinogen; Humans; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Structure-Activity Relationship | 1992 |
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine | 1998 |
Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Binding Sites; Cricetinae; Cross-Linking Reagents; Dimerization; Drug Synergism; Ligands; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Serotonin; Signal Transduction; Thromboxane A2; Tyrosine | 2001 |